Company Description
Alkem started its operations in the country through its fully-owned subsidiary, Alkem Laboratories Corporation, in July 2011. We offer a comprehensive range of specialty products targeting different therapeutic segments for the treatment of patients. We started with Anti-infectives and ventured into Gastroenterology with Proton Pump Inhibitors. Recently, we have added Pain Management and Probiotic therapies to our portfolio. We intend to strengthen our presence in these segments through continuous and strategic new launches.